Citation Impact
Citing Papers
Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning
2006
Wnt Stabilization of β-Catenin Reveals Principles for Morphogen Receptor-Scaffold Assemblies
2013 Science
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
2008
IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38
2008
Esrrb Is a Pivotal Target of the Gsk3/Tcf3 Axis Regulating Embryonic Stem Cell Self-Renewal
2012
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
Nanog Is the Gateway to the Pluripotent Ground State
2009 StandoutNobel
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
2009 StandoutNobel
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
Fasting-induced hormonal regulation of lysosomal function
2017
The regulation of IL-10 production by immune cells
2010 Standout
β-Arrestin Scaffolding of Phosphatidylinositol 4-Phosphate 5-Kinase Iα Promotes Agonist-stimulated Sequestration of the β2-Adrenergic Receptor
2008 StandoutNobel
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
2006
Interleukin‐10: new perspectives on an old cytokine
2008
Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies
2002 Standout
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Recruitment of β-arrestin2 to the dopamine D2 receptor: Insights into anti-psychotic and anti-parkinsonian drug receptor signaling
2008
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
2005
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
2010
Deficiency in the Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3 Increases Sensitivity to Mood Disturbances
2010
Novel Drugs and Therapeutic Targets for Severe Mood Disorders
2008
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Altered expression and subcellular distribution of GRK subtypes in the dopamine‐depleted rat basal ganglia is not normalized byl ‐DOPA treatment
2007
Imaging of cAMP Levels and Protein Kinase A Activity Reveals That Retinal Waves Drive Oscillations in Second-Messenger Cascades
2006 StandoutNobel
Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe disease
2010
The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression
2008
Association between the Casein Kinase 1 Epsilon Gene Region and Subjective Response to D-Amphetamine
2005
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
2004
Glycogen Synthase Kinase 3 Regulates N-Methyl-d-aspartate Receptor Channel Trafficking and Function in Cortical Neurons
2007
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Regulation of BMAL1 Protein Stability and Circadian Function by GSK3β-Mediated Phosphorylation
2009
Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
2009
Understanding the recent evolution of the human genome: insights from human-chimpanzee genome comparisons
2006
A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice
2010
Paradoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice
2006
AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
2007
Neuronal Ca2+-sensor proteins: multitalented regulators of neuronal function
2004
Nonresolving Inflammation
2010 Standout
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Autophagy: Renovation of Cells and Tissues
2011 Standout
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Intracellular Toll-like Receptors
2010 StandoutNobel
β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors
2007
Ancient and Recent Positive Selection Transformed Opioid cis-Regulation in Humans
2005
The executioners sing a new song: killer caspases activate microglia
2011
Targeting the function of the HER2 oncogene in human cancer therapeutics
2007
Wnt/β-Catenin Signaling and Disease
2012 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
The Akt–GSK-3 signaling cascade in the actions of dopamine
2007
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Quantitative Mass Spectrometry Reveals Dynamics of Factor-inhibiting Hypoxia-inducible Factor-catalyzed Hydroxylation
2011 StandoutNobel
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
2015
Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling
2007
Regulation of Akt Signaling by D2and D3Dopamine ReceptorsIn Vivo
2007
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
2009
Calmodulin Controls Synaptic Strength via Presynaptic Activation of Calmodulin Kinase II
2010 StandoutNobel
Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3
2010
Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans
2008
Major Depressive Disorder
2008 Standout
PI3K/Akt: getting it right matters
2008
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
2009
Gsk3 is a metabolic checkpoint regulator in B cells
2017
Inactivation of the Enzyme GSK3α by the Kinase IKKi Promotes AKT-mTOR Signaling Pathway that Mediates Interleukin-1-Induced Th17 Cell Maintenance
2012
AKT/PKB Signaling: Navigating the Network
2017 Standout
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
2005 StandoutNature
Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem Cells
2008
GSK-3: Functional Insights from Cell Biology and Animal Models
2011
The PI3K Pathway in Human Disease
2017 Standout
Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ Pathways
2008
Calcium Signaling
2007 Standout
Regulation of transcription factors by neuronal activity
2002
lincRNAs act in the circuitry controlling pluripotency and differentiation
2011 StandoutNature
The molecular neurobiology of depression
2008 StandoutNature
Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania
2006
Update on Wnt signaling in bone cell biology and bone disease
2011
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons
2007
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
2011
Inflammasomes in health and disease
2012 StandoutNature
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages
2016 Standout
Kinases as drug targets in the treatment of bipolar disorder
2008
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
2013 Standout
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin
2006
Cell Signaling and the Genesis of Neuropathic Pain
2004
Validating GSK3 as an in vivo target of lithium action
2009
Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
2007
Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
2005
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
2008
Possible association of β‐arrestin 2 gene with methamphetamine use disorder, but not schizophrenia
2006
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms
2008
Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size
2011
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
The Histone Demethylase KDM5b/JARID1b Plays a Role in Cell Fate Decisions by Blocking Terminal Differentiation
2008
Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
2014
Reply to Belmaker et al. : GSK3β haploinsufficiency results in lithium-like effects in the forced-swim test
2008
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
2008
A Localized Wnt Signal Orients Asymmetric Stem Cell Division in Vitro
2013 StandoutScienceNobel
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Signaling Pathways Downstream of Pattern-Recognition Receptors and Their Cross Talk
2007
Works of Lisa Kockeritz being referenced
Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation
2008
The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis
2001
DREAM Is a Critical Transcriptional Repressor for Pain Modulation
2002
IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins
2006
Lef1 Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific Manner
2009
Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
2006
Functional Redundancy of GSK-3α and GSK-3β in Wnt/β-Catenin Signaling Shown by Using an Allelic Series of Embryonic Stem Cell Lines
2007
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
2004